Stocks Crossing 50-Day SMA 10/12: (EA) (ECL) (BA) Above; (KEY) (LNKD) (DHI) Below
- ADP Employment Change (Apr) 156K vs 195K Expected
- Wall Street set to open lower as private jobs data weighs
- The Priceline Group (PCLN) Tops Q1 EPS by 88c; Q2 Guidance Below the Street
- Exclusive: Pfizer approaches Medivation about potential takeover - sources
- Pre-Open Stock Movers 05/04: (GKOS) (NTRI) (ZG) (ETSY) Higher; (CRAY) (GLUU) (SYRG) (RLYP) Lower (more...)
Crossing and above:
- Electronic Arts Inc. (Nasdaq: EA) - up 2.1 percent. Moving as NPD said Madden '13 was the best-selling video game last month. Data shows Madden selling 11 percent more than the debut month for Madden '12.
- Ecolab, Inc. (NYSE: ECL) - up 3.9 percent. Announced the acquisition of Champion Technology today for $2.2 billion. In addition, said it sees Q3 adjusted EPS at about 87 cents, the high-end of its range.
- Boeing (NYSE: BA) - up 1.1 percent. On a two-day move higher today, Boeing is getting some positive analyst sentiment today as well.
- KeyCorp (NYSE: KEY) - down 3.2 percent. Lower as peer Wells Fargo (NYSE: WFC) reported a little bit of activity slowdown last quarter in its mortgage division.
- LinkedIn (NYSE: LNKD) - down 1.9 percent. Shrugging off an Evercore Partners upgrade earlier as overall market pressure takes hold today.
- DR Horton Inc. (NYSE: DHI) - down 1.5 percent. Looks like a stronger technical move here. Horton on a two-session slide and just breaking below the 50-day SMA, a level it's been above since the middle of June. MKM downgraded the stock Thursday morning.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Acadia Pharma (ACAD) Up 6% as Trading Resumes Following NUPLAZID Approval
- Valeant Pharma (VRX) is not a 'sewer' - Ackman
- Valeant's (VRX) Improved Credit Outlook Seen as 'Meaningful Positive' at BMO Capital
Create E-mail Alert Related CategoriesSpecial Reports, Technicals, Trader Talk
Related EntitiesWells Fargo, Stocks crossing the 50-day simple moving average
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!